During follicular development, a co-ordinated gonadotrophin and endocrine environment is believed to be essential for normal function of the resulting corpus luteum. Whether differences in the gonadotrophins used to promote follicular development can have lasting effects on granulosa cells after they have undergone luteinization and culture, remains to be studied. We measured steroid production under basal and human chorionic gonadotrophin (HCG) stimulation in short and long term cultures of luteinizing granulosa cells obtained from normal ovulatory women undergoing assisted folliculogenesis with either human menopausal gonadotrophin (HMG) or follicle stimulating hormone (FSH). Basal progesterone and oestradiol production by luteinized granulosa cells obtained from follicles stimulated to develop with FSH was significantly greater than that from HMG derived follicles (P Ͻ 0.001). In short term cultures, treatment with 10 IU HCG caused a 10-fold increase in progesterone release by cells from FSH stimulated follicles, whereas cells of HMG origin produced only 5-fold more progesterone (P Ͻ 0.0001). In cultures that were maintained for 2 weeks, progesterone secretion was reduced, but a similar trend in HCG responsiveness was observed. These experiments demonstrate that the composition of the gonadotrophins used to promote follicular development in vivo leads to differences in granulosa cell steroidogenesis which are evident after luteinization and culture. They additionally support the notion that the environment of follicular development will be reflected in the resulting corpus luteum.
Introduction
In follicles that have been selected to progress, follicle stimulating hormone (FSH) contributes to granulosa cell proliferation and other developmental events, such as steroidogenic enzyme induction and luteinizing hormone (LH) receptor formation. Much later, LH acts on these same cells to reduce their proliferative rate and maximize progesterone synthesis (Hillier, 1994) . The granulosa cell, as the source of aromatase, utilizes thecal cell androgens to produce oestrogen as the follicle matures towards ovulation. Throughout this progression, fine 2064 © European Society for Human Reproduction and Embryology adjustments in both FSH and LH are made through negative and positive feedback regulation on the hypothalamic-pituitary axis by ovarian peptides and steroids. At the local level, many intra-ovarian paracrine factors are also required to ensure successful follicular development (reviewed by Gougeon, 1996; Fauser and Van Heusden, 1997) . In response to the LH surge, cells within the pre-ovulatory follicle undergo their final step of differentiation and luteinize. It could then be assumed that after this developmental progression the granulosa-luteal cells should be functionally equivalent. This, however, is not known with certainty.
The two-cell model indicates a requirement for finely coordinated actions between FSH and LH in promoting follicular development , yet protocols for ovarian stimulation in women use gonadotrophin preparations of varying FSH and LH content. Variations in the type or availability of gonadotrophins throughout this period, while still permitting follicular expansion, may alter the subsequent development of the corpus luteum. Indeed, it has been thought for some time now that a finely tuned gonadotrophin and endocrine environment during follicular development is essential for subsequent corpus luteum function (McNatty, 1979) .
With the current use of reliable pituitary down-regulators in in-vitro fertilization (IVF) programmes, it is now possible to ask the question of whether variation in the amount or type of exogenous gonadotrophins used in promoting follicular development can have effects on granulosa cells after luteinization. We chose two gonadotrophin preparations that are widely used for ovarian stimulation and that vary significantly in their constituents. Human menopausal gonadotrophin (HMG) is obtained from the urine of postmenopausal women and contains 75 IU each of both FSH and LH per ampoule. A second, and more recently introduced preparation, is a highly purified human urinary FSH that is reported to contain 75 IU of FSH and Ͻ1 IU of LH per ampoule. The purpose of this study, therefore, was to investigate granulosa-luteal cell steroidogenesis to determine whether the environment of follicular development can affect these cells after subsequent developmental stages such as luteinization.
Materials and methods

Cell preparation and culture
Granulosa-luteal cells were obtained from spontaneously ovulating women who were undergoing ovarian stimulation for IVF. The short (flare-up) protocol was used for down regulation of the hypothalamicpituitary axis. The gonadotrophin-releasing hormone agonist (GnRHa) leuprolide acetate, at a dose of 0.5 mg, was self-administered s.c. twice daily from day 1 of the menstrual cycle until human chorionic gonadotrophin (HCG) was given. Ovarian stimulation commenced on day 3 with two ampoules of either HMG (Pergonal; Serono Laboratories, Mississauga, Ontario, Canada) or FSH (Metrodin; Serono). Monitoring of follicular development was as described previously (Daya et al., 1995) . When at least two follicles had reached a diameter of 18 mm, 10 000 IU of HCG (Profasi HP; Serono) was administered and oocytes were retrieved by ultrasound guided transvaginal aspiration 34-36 h later.
After the removal of cumulus-oocyte complexes, cells were recovered from follicular aspirates by centrifugation at 250 g for 10 min. The pellet was resuspended in a minimal volume of Hanks' balanced salt solution (HBSS) and red blood cell numbers were reduced by centrifugation at 500 g for 20 min over a 60% Percoll cushion. Granulosa-luteal cells were then washed to remove Percoll, resuspended in culture media and counted in a haemocytometer. The cells were cultured in triplicate at 100 000 cells per well in 24-well culture dishes (Nunc, Copenhagen, Denmark) in 0.5 ml medium. Culture medium consisted of Eagle's minimum essential medium with Earle's salts and was buffered with 2.5 g/l NaHCO 3 and 1.5 mM HEPES. The medium was further supplemented with 10% calf serum, 2 mM L-glutamine, 0.1 mM non-essential amino acids, 100 IU/ml penicillin, 100 µg/ml streptomycin, 50 µg/ml gentamicin and 1.2 µg/ml Fungizone (Gibco, Grand Island, NY, USA). Cells were allowed to attach overnight and were then washed with two changes of HBSS to remove unattached cells and debris. The medium was replaced with and without tissue culture grade HCG (10 IU/well) (Calbiochem, La Jolla, CA, USA) in triplicate wells, collected at 48 h and stored at -20°C until assayed. After media collection, the wells were rinsed twice with HBSS and stored dry for the subsequent determination of protein content.
To determine if the differences seen in luteinized granulosa cell steroidogenesis were persistent, cultures were maintained for 2 weeks in culture. Media were collected at 48 h intervals and after the day 8 collection, half the wells were treated with 10 IU HCG for the remainder of the experiment. The protein content of the wells at the end of the experiment was used for normalization.
Assays
Radioimmunoassays for progesterone and oestradiol were performed without extraction using high specific activity 3 H-oestradiol and 3 Hprogesterone (Dupont, Mississauga, Ontario, Canada) as described previously (Younglai, 1985) . The sensitivity of the assay for progesterone was 0.2 ng/ml with inter-and intra-assay coefficients of variation from 8 to 12%. The oestradiol assay had a sensitivity of 20 pg/ml and had similar coefficients of variation.
The contents of the wells were solubilized in 0.1 M NaOH after the final media collections and the protein content was determined by a commercial colorimetric assay (Bio-Rad, Richmond, CA, USA). Data were expressed as steroid production per µg granulosa-luteal cell protein. Normalization of results based on protein determination has previously been shown to be equally as efficient as normalization based on DNA content of granulosa cell cultures (May and Schomberg, 1984) .
Cultures were plated and treated in triplicate, and each experiment represents pooled cells from one individual. Means and SDs were calculated and comparisons were made using Student's t-test.
Results
In all experiments, the viability of the granulosa-luteal cells at the time of plating was Ͼ90%. Equal numbers of viable cells were plated for each treatment. At the end of culture, the data were normalized per µg of protein. There were no 2065 differences in protein content, indicating that the increased steroid production by the cultures derived from FSH primed follicles did not result from the presence of more cells, a different plating efficiency or from an increase in cell number during the culture period. In addition, cultures were established to optimize steroid production. Bar-Ami and Gitay-Goren (1993) have demonstrated that human granulosa-luteal cell cultures at a density of 60 000 cells/cm 2 produce maximal amounts of progesterone when compared with cultures at higher and lower densities. Our cultures at 100 000 viable cells per well in 24-well culture plates would have resulted in a cell density of~57 000 cells/cm 2 , implying that our cell cultures were producing progesterone optimally.
Basal progesterone production from luteinized granulosa cell cultures obtained from follicles stimulated to develop with high purity FSH was almost twice that of similar cultures derived from follicles promoted to develop with HMG (22.1 Ϯ 0.3 versus 13.6 Ϯ 3.7 ng/µg protein respectively, P Ͻ 0.001). Following stimulation with 10 IU of HCG, progesterone production in granulosa-luteal cell cultures derived from FSH primed follicles increased 10-fold compared to only a 5-fold increase in cultures obtained from HMG priming (216.3 Ϯ 9.5 versus 68.2 Ϯ 10.5 ng/µg protein respectively, P Ͻ 0.0001) (Figure 1) .
Production of oestradiol was lower than that of progesterone from these luteinized granulosa cell cultures and was expressed as pg per 100 µg of plated protein. A significant difference in oestradiol production was observed between the two groups. The content of oestradiol was significantly higher in cultures obtained from follicles stimulated to develop with FSH (135.6 Ϯ 1.5 pg/100 µg protein) than that of the HMG group (63.0 Ϯ 9.0 pg/100 µg protein, P Ͻ 0.0002). Similarly, oestradiol production in cultures supplemented with 10 IU HCG increased approximately 4-fold to 413 Ϯ 45.5 pg/100 µg protein in the FSH group and only 3-fold (204.0 Ϯ 5.1 pg/100 µg protein/ 96 h) in the HMG group (P Ͻ 0.0006) (Figure 1) .
In further experiments, cells were maintained in culture for 2 weeks. This would approximate the time, that if left in vivo, the granulosa-luteal cells would have been exposed to endogenous HCG in a conceptive cycle. Progesterone production declined with time in all cultures whether the cells were obtained from FSH or HMG primed follicles. After 8 days in culture, 10 IU of HCG was added to half the wells. Cultures receiving HCG increased progesterone production over the next two collection periods, with a peak occurring at day 12 (Figure 2 ). The response of the granulosa-luteal cells obtained from FSH primed follicles was greater than that of the HMG derived cells. At the peak, these HCG stimulated cells had increased progesterone secretion 4-fold, from 9.8 Ϯ 3.7 ng/ µg protein to 39.4 Ϯ 10.7 ng/µg protein, whereas the HMG derived cultures appeared to have doubled; however, the increase was not statistically significant (9.9 Ϯ 2.8 ng/µg protein versus 21.6 Ϯ 8.3 ng/µg protein).
Discussion
The follicular steroid producing cells that receive the ovulatory stimulus and complete their differentiation programme to go on and form luteal cells do not show significant mitosis. This has led some to propose that the quality of the resultant corpus luteum probably depends on the state of the follicle from which it was formed (McNatty, 1979; Leymarie and Martal, 1993) . In other words, the corpus luteum can reflect the hormonal environment of its follicle of origin. This notion, however, has yet to be demonstrated in humans. At present, the effects of using different gonadotrophic stimulation protocols during the follicular phase on subsequent luteal cell function in vitro are equivocal. Earlier studies comparing in vitro granulosa luteal cell progesterone and oestrogen production from patients who were given HMG or FSH to promote follicular development, showed no differences between cultures. In these studies, however, pituitary suppression was not employed, so that influences from endogenous gonadotrophins were likely to have occurred (Polan et al., 1986; Hill and Osteen, 1992) . Now, with the use of compounds that are reported to down regulate the pituitary's own gonadotrophin 2066 secretion it is possible to study the effects of exogenous gonadotrophins on the post-ovulatory function of human granulosa cells. The data from this study indicate that luteinized granulosa cells obtained from different stimulation protocols are indeed different, at least at the level of steroids released in vitro. Those obtained from FSH (Metrodin) primed follicles have a greater steroidogenic capacity in culture than do those cells collected from follicles that had been induced to develop with equal amounts of LH and FSH (Pergonal) . The cell cultures were derived from spontaneously ovulating women undergoing ovarian stimulation and were selected randomly over the course of a few months. In an associated larger study (Daya et al., 1995) , it was shown that female age, duration and amount of gonadotrophin used, as well as number of follicles that developed and oocyte number retrieved were not significantly different between the two groups. Thus, the only difference between the two groups was in the gonadotrophin that was used. Our results reflect the response of the granulosa-luteal cells to enhanced development under two different stimulation environments.
Using pre-ovulatory human granulosa cells, Yong et al. (1994) have shown that variations in the types of gonadotrophins that were used to stimulate the cells lead to striking differences in cyclic AMP levels and also in steroidogenic enzymes that were expressed. Our findings would indicate that changes of this type are not reversed or eliminated after ovulation, despite the cells having undergone a final step in their developmental pathway (luteinization). Findings of a similar nature have been reported by Zelinski-Wooten et al. (1995) in rhesus monkeys. In their study, pituitary suppressed monkeys were treated with recombinant FSH or recombinant FSH and recombinant LH to induce follicular development, followed by an ovulatory dose of HCG. The resultant granulosa-luteal cell cultures from FSH stimulated monkeys appeared to produce more progesterone than those derived from FSH:LH primed monkeys in 1 day old cultures, albeit the differences did not reach statistical significance.
Whether the lower steroid release in human granulosa-luteal cell cultures obtained by FSH:LH (HMG) priming is indicative of excessive LH cannot be determined with certainty at this time. Elevated LH throughout the pre-ovulatory period has been proposed negatively to influence post-ovulatory events such as conception and implantation (Chappel and Howles, 1991) and may well have similar effects on granulosa cells after luteinization. The flare-up protocol that was used leads to an initial release of FSH and LH and this could possibly have diminished the differences between the FSH and HMG responses. This, however, is likely to be minimal as the number of granulosa cells in selectable follicles (2-5 mm in diameter) at the start of treatment is Ͻ1ϫ10 6 , whereas in pre-ovulatory follicles the number of granulosa cells is~60ϫ10 6 (Gougeon, 1996) . Therefore the majority of granulosa cells grew and developed in an environment stimulated by either FSH or HMG.
Whether our findings will ultimately have clinical relevance for future ovarian stimulation protocols is unknown at this time. Studies in the past, that have tried to demonstrate the superiority of one of these two gonadotrophin preparations in terms of IVF success rates and other associated clinical parameters have been unsuccessful. Recent work (Imthurn et al., 1996; Mercan et al., 1997) showing improved oocyte nuclear maturity and morphology with FSH versus HMG priming are now the possible exceptions. Likewise, granulosa cells from FSH-primed monkeys enhanced the developmental competence of in-vitro matured oocytes (Schramm and Bavister, 1996) . It was not, however, our aim to demonstrate the superiority of one preparation over the other, but rather to use these different preparations to study their effects on granulosa cell development as measured by post-ovulatory steroidogenesis in vitro. We found that the two different gonadotrophin preparations used to promote granulosa cell development do lead to persistent differences in granulosa cell steroid secretion after luteinization. This also indicates that future studies on endocrine physiology of human granulosaluteal cells in vitro should now take the source of cells (i.e. the gonadotrophin mix used for priming) into consideration.
